Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05042999 · ClinicalTrials.gov registry record · NA

The Use of Virtual Reality During Breast Ultrasound-Guided Biopsy Procedures

A NA study, sponsored by Prisma Health-Upstate.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT05042999: Completed NA study, sponsored by Prisma Health-Upstate.

NCT05042999 is a NA study that has completed, run by Prisma Health-Upstate. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05042999, a NA study, has completed, sponsored by Prisma Health-Upstate.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

To determine if a virtual reality simulation will reduce pain and anxiety in patients undergoing an ultrasound guided breast biopsy procedure.

Primary Outcome

Pain Measured with the Visual Analog Scale. Visual Analogue Scale (VAS) is a measurement instrument that tries to measure a characteristic or attitude that is believed to range across a continuum of values and cannot easily be directly measured. The individual will score their pain level by circling a number 0 - 10 both pre-operative and post-operatively. The scale range includes 0-10 scales, with \< 2 =well controlled, 2 - 5: partly controlled, \> 5: uncontrolled.

Interventions

  • DEVICE Oculus Go Virtual Reality Goggles

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2021-09-15
Est. Completion 2022-01-07
Phase NA
Prisma Health-Upstate

67 total trials

What the finished NCT05042999 record still lists

NCT05042999 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Oculus Go Virtual Reality Goggles is the first listed.

NCT05042999 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05042999 about?

NCT05042999 is a clinical study titled "The Use of Virtual Reality During Breast Ultrasound-Guided Biopsy Procedures". To determine if a virtual reality simulation will reduce pain and anxiety in patients undergoing an ultrasound guided breast biopsy procedure.

What is the current status of trial NCT05042999?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2021-09-15. Estimated completion is 2022-01-07.

What interventions are being tested in trial NCT05042999?

The interventions under investigation include: Oculus Go Virtual Reality Goggles (DEVICE).

Who is sponsoring clinical trial NCT05042999?

This trial is sponsored by Prisma Health-Upstate, which has 67 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05042999's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05042999, the US trial registry maintained by the National Library of Medicine. NCT05042999 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.